Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Contango Silver & Gold VP Sells Shares for Tax Withholding

David Gregory Larimer, VP Exploration at Contango Silver & Gold Inc., filed a Form 4 on August 19, 2026, reporting the sale of 96 shares of common stock at a weighted average price of $20.94, with the transaction tied to tax obligations arising from …

Manish Choudhary | 19 August 2026

Unity Software CEO Receives 880,000 Performance Stock Units

Unity Software Inc. filed a Form 8-K on August 19, 2026, disclosing that its Human Capital and Compensation Committee approved a special grant of 880,000 performance-based, price-vesting restricted stock units to President and CEO Matthew Bromberg on August 17, 2026.

Manish Choudhary | 19 August 2026

Contango Silver & Gold CFO Sells 1,289 Shares in Tax Withholding Transaction

Michael Aaron Clark, Chief Financial Officer of Contango Silver & Gold Inc. (NYSE:CTGO), filed a Form 4 on August 19, 2026, disclosing the sale of 1,289 shares of common stock in connection with the vesting of restricted stock on August 18, 2026.

Aditi Sarkar | 19 August 2026

HIVE Digital's BUZZ Unit Signs $350M GPU Cloud Deal

HIVE Digital Technologies Ltd. filed a Form 8-K on August 19, 2026, disclosing that its wholly-owned subsidiary BUZZ High Performance Computing Inc. entered into a five-year GPU cloud services agreement valued at approximately $350 million with an unnamed enterprise customer.

Vinay Lochav | 19 August 2026

Unity Software CEO Receives 880,000 Performance Stock Units

Matthew S. Bromberg, President and CEO of Unity Software Inc. (NYSE:U), filed a Form 4 on August 18, 2026, disclosing the acquisition of 880,000 performance-based price vesting restricted stock units granted on August 17, 2026.

Vinay Lochav | 19 August 2026

Twist Bioscience Files Prospectus Supplement for Invenra Share Resale

Twist Bioscience Corporation filed a Form 8-K on August 19, 2026, disclosing the filing of a prospectus supplement to register the resale of shares issuable to Invenra Inc. under agreements dated February 11, 2026.

Nitish Kishor | 19 August 2026

FDA Grants Accelerated Approval for Ultragenyx Gene Therapy

Ultragenyx Pharmaceutical Inc. filed an 8-K with the U.S. Securities and Exchange Commission on August 19, 2026, announcing that the FDA granted accelerated approval for GENGLYCOS (pariglasgene brecaparvovec-opnr) in adult and pediatric patients eight years and older with glycogen storage disease type Ia.

Aditi Sarkar | 19 August 2026

Encore Capital Group Appoints Robert Beck to Board

Encore Capital Group, Inc. filed a Form 8-K with the SEC on August 19, 2026, disclosing the appointment of Robert Beck as a new independent director and the expansion of the Board of Directors from 8 to 9 members.

Manish Choudhary | 19 August 2026

BKV Corporation Files 10-K/A for Fiscal Year 2025

BKV Corporation filed a Form 10-K/A (Amendment No. 1) on August 19, 2026, amending its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, originally filed with the SEC on March 6, 2026, to correct auditor consent language, recast financial …

Manish Choudhary | 19 August 2026

Kimball Electronics Files Annual Report for Fiscal 2026

Kimball Electronics, Inc. filed its Form 10-K annual report with the U.S. Securities and Exchange Commission for the fiscal year ended June 30, 2026, disclosing financial and operational details including a subsequent-event acquisition and share data as of August 6, 2026.

Anjali Anand | 19 August 2026
Support

Hi! How can we help you today?

Loading…